EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 18 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,306,000 | +1.3% | 130,290 | +0.2% | 0.26% | +6.6% |
| Q2 2022 | $1,289,000 | -5.6% | 130,072 | -6.0% | 0.24% | -9.7% |
| Q1 2022 | $1,365,000 | +9.4% | 138,373 | +10.6% | 0.27% | 0.0% |
| Q4 2021 | $1,248,000 | +0.2% | 125,064 | -0.5% | 0.27% | -11.0% |
| Q3 2021 | $1,246,000 | +4.4% | 125,700 | +7.4% | 0.30% | +0.7% |
| Q2 2021 | $1,194,000 | +1.4% | 117,054 | 0.0% | 0.30% | -6.3% |
| Q1 2021 | $1,177,000 | -15.0% | 117,054 | -9.9% | 0.32% | -53.6% |
| Q4 2020 | $1,385,000 | – | 129,880 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 248,674 | $2,578,749 | 1.28% |
| Verition Fund Management LLC | 397,603 | $4,115,191 | 0.06% |
| CLEAR STREET LLC | 2,740 | $28 | 0.00% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1 | $10 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |